negative regulation of G protein-coupled receptor signaling pathway

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of G protein-coupled receptor signaling pathway. [GOC:go_curators]

Negative regulation of G protein-coupled receptor (GPCR) signaling pathway is a crucial process that fine-tunes and controls the diverse cellular responses mediated by GPCRs. GPCRs are transmembrane proteins that bind a wide range of extracellular ligands, including hormones, neurotransmitters, and odorants. Upon ligand binding, GPCRs activate intracellular signaling cascades that influence various cellular functions, ranging from cell growth and differentiation to metabolism and sensory perception. To prevent excessive or inappropriate signaling, cells have evolved intricate mechanisms to negatively regulate GPCR activity. This negative regulation occurs at multiple levels, including receptor desensitization, signaling pathway termination, and feedback loops involving downstream effectors.

**1. Receptor Desensitization:**
- **Phosphorylation:** Upon prolonged GPCR activation, specific kinases, such as GRKs (G protein-coupled receptor kinases) and PKA (protein kinase A), phosphorylate the receptor's intracellular tail. Phosphorylation creates docking sites for arrestins, a family of adaptor proteins that bind to phosphorylated GPCRs.
- **Arrestin Binding:** Arrestin binding physically prevents the GPCR from interacting with G proteins, effectively inhibiting further signal transduction. Arrestins also promote the internalization of the GPCR, removing it from the cell surface and reducing the number of active receptors.

**2. Signaling Pathway Termination:**
- **GTPase Activity:** The Gα subunit of the heterotrimeric G protein possesses intrinsic GTPase activity. After activation by the GPCR, Gα hydrolyzes GTP to GDP, returning to its inactive state and dissociating from the receptor and Gβγ dimer. This terminates the signaling cascade by preventing further activation of downstream effectors.
- **Phosphodiesterases:** Signaling pathways involving cAMP as a second messenger are often regulated by phosphodiesterases, enzymes that break down cAMP, reducing its concentration and attenuating the signal.

**3. Feedback Loops:**
- **Downstream Effector Regulation:** Some downstream effectors of GPCR signaling pathways can negatively regulate their own activation. For example, certain GPCR-activated kinases can phosphorylate and inhibit the GPCR itself, creating a negative feedback loop.
- **Transcriptional Regulation:** Activation of GPCR signaling can trigger the transcription of genes that encode negative regulators of the pathway, providing a long-term mechanism for controlling signal intensity.

**4. Other Mechanisms:**
- **Protein Degradation:** GPCRs can be targeted for degradation by ubiquitination, a process that marks proteins for proteasomal degradation. This reduces the overall number of GPCRs in the cell.
- **Lipid Modification:** Some GPCRs undergo palmitoylation, a type of lipid modification that regulates their localization and trafficking. This can influence GPCR activity by affecting its access to signaling partners.

**Overall, negative regulation of GPCR signaling is essential for maintaining cellular homeostasis and preventing aberrant signaling. By finely tuning GPCR activity, cells can ensure that their responses to external stimuli are appropriate and controlled. These regulatory mechanisms are highly complex and involve a coordinated interplay of proteins, enzymes, and signaling molecules.**'
"

Proteins (8)

Compounds (165)